Effects of losartan and captopril on reversing myocardial remodeling
Liu Yuan-sheng
Abstract
Liu Yuan-sheng
Abstract
Objective:To investigate the effects of losartan and captopril on reversing myocardial remodeling.Methods:Twenty-four Wistar rats were randomly divided into four groups-sham group,Infarcted group,losartan group, captopril group. c-fos mRNA expression was tested by reverse transcription and polymerase chain reaction(RT-PCR). Expression changes of cardiac collagen subtype Ⅰ, Ⅲ, fibronectin(FN) proteins were studied with immunohistochemistry and image analysis.Results:c-fos mRNA expression was enhanced on the 21st day after myocardial infarction ,and expressions of collagen Ⅰ, collagen Ⅲ and FN formation in infarcted group were significant(P 0.05 and P 0.01) on the 21st day compared with those in sham group respectively. In losartan group and captopril group, c-fos mRNA expression was inhibited ,and cardiac collagenⅠ, collagen Ⅲ, FN expressions were remarkably decreased (P 0.05 or P 0.01) compared with those in infarcted group, respectively.Conclusion:Losartan and captopril can downregulate c-fos mRNA expression, inhibite cardiac collagenⅠ, collagen Ⅲ, FN formation, and reverse myocardial remodeling after myocardial infarction. Effect of AT 1 receptor blocker on reversing myocardial remodeling is similar to that of angiotensin-converting enzyme inhitor.The results indicate that angiotensin-converting enzyme inhitor and AT 1 receptor blocker can substitute for each other.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effects of losartan and captopril on reversing myocardial remodeling.Methods:Twenty-four Wistar rats were randomly divided into four groups-sham group,Infarcted group,losartan group, captopril group. c-fos mRNA expression was tested by reverse transcription and polymerase chain reaction(RT-PCR). Expression changes of cardiac collagen subtype Ⅰ, Ⅲ, fibronectin(FN) proteins were studied with immunohistochemistry and image analysis.Results:c-fos mRNA expression was enhanced on the 21st day after myocardial infarction ,and expressions of collagen Ⅰ, collagen Ⅲ and FN formation in infarcted group were significant(P 0.05 and P 0.01) on the 21st day compared with those in sham group respectively. In losartan group and captopril group, c-fos mRNA expression was inhibited ,and cardiac collagenⅠ, collagen Ⅲ, FN expressions were remarkably decreased (P 0.05 or P 0.01) compared with those in infarcted group, respectively.Conclusion:Losartan and captopril can downregulate c-fos mRNA expression, inhibite cardiac collagenⅠ, collagen Ⅲ, FN formation, and reverse myocardial remodeling after myocardial infarction. Effect of AT 1 receptor blocker on reversing myocardial remodeling is similar to that of angiotensin-converting enzyme inhitor.The results indicate that angiotensin-converting enzyme inhitor and AT 1 receptor blocker can substitute for each other.
Key concepts: Losartan, Captopril, Medicine, Myocardial infarction, Internal medicine, Endocrinology, Fibronectin, Messenger RNA